Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-2.76M.
ENTERPRISE VALUE (EV)
$-2.76M
Onconetix, Inc.
Market Cap
$2.44M
Enterprise Value (EV)
$-2.76M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Onconetix, Inc. (ONCO) | $2.44M | $-2.76M |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.41M | $2.52M |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.37M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.37M | $12.43M |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | $462166.00 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | $1.55M |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.33M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.18M | $12.54M |
| GeoVax Labs, Inc. (GOVX)vs › | $2.17M | N/A |
Market Cap
$2.44M
Total Debt
$24362.00
Cash
$5.22M
Enterprise Value
$-2.76M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
